MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression-Reference-Cited by-同舟云学术

MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression

Published:2016-06-23 Issue:31 Volume:7 Page:49217-49231
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

de Melo Maia Beatriz¹²,Rodrigues Iara Santana¹,Akagi Erica Mie¹,Soares do Amaral Nayra¹,Ling Hui²,Monroig Paloma²,Soares Fernando Augusto¹,Calin George Adrian²³,Rocha Rafael Malagoli⁴

Affiliation:

1. Molecular Morphology Laboratory, Anatomic Pathology Department, AC Camargo Cancer Center, São Paulo, Brazil

2. Department of Experimental Therapeutics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

3. The Center for RNA Interference and Non-Coding RNAs, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

4. Gynecology Laboratory, Gynecologic Department Federal University of São Paulo, São Paulo, Brazil

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-223-5p serves as a diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI;BMC Cardiovascular Disorders;2024-08-13

2. The roles played by hsa-miR-223-5p and mutations in the S gene of SARS-CoV-2 in COVID-19;Laboratory Medicine;2024-08-05

3. Role of non-coding RNAs in vulvar cancer;Current Cancer Therapy Reviews;2024-07-23

4. Mechanism of HCG regulating epithelial–mesenchymal transition progression in endometrial cells through the FoxO1/miR223-5p/Wnt5α pathway;Reproductive BioMedicine Online;2024-01

5. Aberrant DNA methylation signatures in gynecological malignancies;Epigenetics in Human Disease;2024